Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Silent Threat of the Coronavirus: America’s Dependence on Chinese Pharmaceuticals

Health + Wellness
Silent Threat of the Coronavirus: America’s Dependence on Chinese Pharmaceuticals
Residents wear protective masks in the supermarket on Feb. 12, 2020 in Wuhan, Hubei province, China. Stringer / Getty Images

By Christine Crudo Blackburn, Andrew Natsios Gerald W Parker and Leslie Ruyle

As the new coronavirus, called 2019-nCoV, spreads rapidly around the globe, the international community is scrambling to keep up. Scientists rush to develop a vaccine, policymakers debate the most effective containment methods, and health care systems strain to accommodate the growing number of sick and dying. Though it may sound like a scene from the 2011 movie "Contagion," it is actually an unfolding reality.


In the midst of all of this, a potential crisis simmers in the shadows: The global dependence on China for the production of pharmaceuticals and medical equipment.

Chinese Dominance in the Pharmaceutical Market

We represent an interdisciplinary group of scientists and policymakers at the Scowcroft Institute's Pandemic and Biosecurity Policy Program based at the Bush School of Government at Texas A&M University who have been holding annual summits addressing pandemic-related issues for the past five years. One of our goals is to promote dialogue on potential risks related to pandemics and U.S. security, in this case the disruption of supply chains and availability of medical supplies and drugs.

Today, about 80% of pharmaceuticals sold in the U.S. are produced in China. This number, while concerning, hides an even greater problem: China is the largest and sometimes only global supplier for the active ingredient of some vital medications. The active ingredients for medicines that treat breast cancer and lung cancer and the antibiotic Vancomycin, which is a last resort antibiotic for some types of antimicrobial resistant infections, are made almost exclusively in China. Additionally, China controls such a large market portion of heparin, a blood thinner used in open-heart surgery, kidney dialysis and blood transfusions that the U.S. government was left with no choice but to continue buying from China even after a contamination scandal in 2007.

China is not only the dominant global supplier of pharmaceuticals, but it is also the largest supplier of medical devices in the U.S. These include things like MRI equipment, surgical gowns, and equipment that measures oxygen levels in the blood. Supplies of these essential products have not yet been severely disrupted by the coronavirus, but if China is no longer will or able to supply them to the U.S., thousands of Americans could die.

More concerning still are the limited options available to the U.S. and the rest of the globe to make up the shortfall. It could take years to develop the necessary infrastructure to reestablish U.S. manufacturing capacities and obtain Food and Drug Administration licensure to overcome the loss of the Chinese supply.

When a disease reaches epidemic levels, the first obligation for leaders in any country is to protect their own people. As this current crisis progresses, there may come a point when political leaders in China will face decisions on whether to prohibit the export of pharmaceuticals, medical devices and other vital medical components in order to treat or protect their own people. Such acts would be the logical outcome of an escalating situation. For the 2009 H1N1 pandemic response, for example, the U.S. was pushed to the back of the queue for vaccine deliveries even though we had existing contracts with a major vaccine manufacturer located in another country. Those vaccine deliveries were delayed.

Disruption of Global Pharmaceuticals?

While a total loss of active ingredient imports from China might seem far-fetched, we believe the increasing scale of the outbreak moves it closer to the realm of possibility.

About six weeks into international recognition of the epidemic in China, there are already shortages of vital personal protective equipment in both China and the U.S. UPS has transported more than 2 million masks and 11,000 gowns to Wuhan to help alleviate the shortage. But what happens when everyone runs out of protective equipment?

Wuhan is a significant player in the biotechnology and pharmaceutical industry, with multiple pharmaceutical companies located in the city. How many of these factories have closed as a result of the pandemic, and when will those that have closed open back up? Global supply chains could reach a crisis point if they are compromised because Hubei province, where Wuhan is located, is in quarantine and factories are shut down.

Additionally, Wuhan is the location of China's first Biosafety Level (BSL) 4 laboratory, which was opened in 2017 to research SARS and other emerging diseases. It is the only lab in China that can safely handle the world's most dangerous pathogens that pose a significant risk of transmission. Infection, death and quarantine in Wuhan and the surrounding Hubei province is restricting the ability of all types of commerce in the region. Meanwhile, the virus is already creating a significant supply chain imbalance within China. That means those medical supply companies will be under pressure to keep any products produced within the country for protection of their own health care workers, laboratory personnel and the general public.

The regulatory apparatus to insure that the Chinese manufactured pharmaceuticals being exported meet the highest standards of safety and quality control are weak or nonexistent, according to a congressional report last year. The pressure placed on supply chains by the outbreak could further exacerbate existing quality control challenges. In doing so, the virus has highlighted our reliance on China as a U.S. national security issue due to outsourcing our manufacturing capabilities and inability to ensure quality control.

As with all pandemics, the complexity of this outbreak demands international collaboration and transparency. At the same time, U.S. public health officials must acknowledge the country's vulnerability due to our dependence on Chinese production of pharmaceuticals and medical equipment. The U.S. must develop a response plan for the inevitable shortages in the near-term and take necessary actions to reclaim control of our medical supply chain. Continuing to overlook this long-known vulnerability will only lead to catastrophe.

Christine Crudo Blackburn is a postdoctoral research fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University.

Andrew Natsios is the director of the Scowcroft Institute of International Affairs and Executive Professor, Texas A&M University.

Gerald W Parker is the associate dean for Global One Health, College of Veterinary Medicine & Biomedical Sciences; and the Director for the Pandemic and Biosecurity Policy Program, Scowcroft Institute for International Affairs, Bush School of Government and Public Service, Texas A&M University.

Leslie Ruyle is the assistant director at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University.

Disclosure statement: Andrew Natsios is affiliated with the Bush School of Government, The Hudson Institute, Scowcroft Institute at the Bush School of Government at Texas A&M Univ, and Fio Corp.

Christine Crudo Blackburn, Gerald W Parker, and Leslie Ruyle do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Reposted with permission from The Conversation.

EcoWatch Daily Newsletter

Atlantic puffins courting at Maine Coastal Island National Wildlife Refuge in 2009. USFWS / Flickr

When Europeans first arrived in North America, Atlantic puffins were common on islands in the Gulf of Maine. But hunters killed many of the birds for food or for feathers to adorn ladies' hats. By the 1800s, the population in Maine had plummeted.

Read More Show Less
Rescue workers dig through the rubble following a gas explosion in Baltimore, Maryland on Aug. 10, 2020. J. Countess / Getty Images

A "major" natural gas explosion killed two people and seriously injured at least seven in Baltimore, Maryland Monday morning.

Read More Show Less
The recalled list includes red, yellow, white and sweet yellow onions, which may be tainted with salmonella. Pxhere

Nearly 900 people across the U.S. and Canada have been sickened by salmonella linked to onions distributed by Thomson International, the The New York Times reported.

Read More Show Less
Methane flares at a fracking site near a home in Colorado on Oct. 25, 2014. WildEarth Guardians / Flickr

In the coming days, the U.S. Environmental Protection Agency (EPA) is expected to use its power to roll back yet another Obama-era environmental protection meant to curb air pollution and slow the climate crisis.

Read More Show Less
Researchers on the ICESCAPE mission, funded by NASA, examine melt ponds and their surrounding ice in 2011 to see how changing conditions in the Arctic affect the biological and chemical makeup of the ocean. NASA / Flickr

By Alex Kirby

The temperature of the Arctic matters to the entire world: it helps to keep the global climate fairly cool. Scientists now say that by 2035 there could be an end to Arctic sea ice.

Read More Show Less
President Vladimir Putin is seen enjoying the Opening Ceremony of the Sochi 2014 Winter Olympics in Sochi, Russia. Pascal Le Segretain / Getty Images

Russia's Health Ministry has given regulatory approval for the world's first COVID-19 vaccine after less than two months of human testing, President Vladimir Putin said on Tuesday.

Read More Show Less

Trending

A John Deere agricultural tractor sits under a collapsed building following a derecho storm on Aug. 10, 2020 near Franklin Grove, Illinois. Daniel Acker / Getty Images

A powerful series of thunderstorms roared across the Midwest on Monday, downing trees, damaging structures and knocking out power to more than a million people.

Read More Show Less